ARTICLE | Clinical News
YSPSL: Phase II started
May 7, 2007 7:00 AM UTC
The company began a single-dose, double-blind, placebo-controlled, U.S. Phase II trial in 12 patients undergoing cadaveric orthotopic liver transplantation. ...
Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
The company began a single-dose, double-blind, placebo-controlled, U.S. Phase II trial in 12 patients undergoing cadaveric orthotopic liver transplantation. ...